LIMK2 Is a Novel Prognostic Biomarker and Correlates With Tumor Immune Cell Infiltration in Lung Squamous Cell Carcinoma

Previous research found that LIM domain kinase 2 (LIMK2) expression correlated with a poor prognosis in many cancers. However, its role in lung squamous cell carcinoma (LUSC) has not yet been clarified. Our study aimed to clarify the role of LIMK2 in LUSC prognosis prediction and explore the relatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yongcheng, Xu, Beibei, Shen, Qianwen, Lei, Ziyu, Zhang, Wenqing, Hu, Tianhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902256/
https://www.ncbi.nlm.nih.gov/pubmed/35273591
http://dx.doi.org/10.3389/fimmu.2022.788375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902256/
https://www.ncbi.nlm.nih.gov/pubmed/35273591
http://dx.doi.org/10.3389/fimmu.2022.788375

Ejemplares similares